CME GROUP INC. 8-K

What Happened

• CME Group Inc. filed an 8-K reporting the results of its 2026 Annual Meeting of Shareholders held May 14, 2026 (record date March 16, 2026). A total of 318,466,544 shares (87.78% of issued and outstanding) were present in person or by proxy. All Equity Director nominees were elected to serve until the 2027 annual meeting. Because several Class B share classes did not reach the required 33.3% quorum, proposals listed as Items 4–8 were adjourned to a virtual meeting on June 9, 2026 at 11:00 a.m. Central Time.

Key Details

• Total shares issued and outstanding (record date March 16, 2026): 362,808,081.
• Shares present at the meeting: 318,466,544 (87.78% of issued and outstanding).
• Broker non-votes for director and say-on-pay items: 23,505,825.
• Auditor ratification (Ernst & Young LLP) approved: FOR 291,376,905; AGAINST 26,595,015; ABSTAIN 494,624.
• Advisory vote on executive compensation (say-on-pay) approved: FOR 259,576,112; AGAINST 34,530,288; ABSTAIN 854,319.

Why It Matters

• The election of the Equity Directors and the ratification of the auditor are completed governance actions that affect board composition and the company’s audited financial reporting. The adjournment of several Class B proposals to June 9 means shareholders holding those Class B series have additional opportunity to vote, and final outcomes for Items 4–8 will be decided at the reconvened virtual meeting. Investors should note the quorum shortfall among certain Class B shares (threshold = 33.3%) and, if relevant, monitor the June 9 results for any material governance changes.